Immunology Today—July 8, 2026
This week’s Immunology update highlights regulatory progress, late-stage…
Immunology Today—July 1, 2026
This week’s Immunology update highlights regulatory decisions, clinical trial…
Immunology Today—May 27, 2026
This week’s Immunology update highlights regulatory progress, reimbursement…
Immunology Today—May 13, 2026
This week’s Immunology update highlights regulatory actions, clinical progress,…
Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D deal for JNJ-4804
Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D…
Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery deal
Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery…
Immunology Video Recap—March 11, 2026
This biweekly Immunology video recap highlights regulatory approvals,…
Immunology Today—March 11, 2026
This week’s Immunology update highlights regulatory progress, positive…
Lucid Diligence Brief: Teva and Blackstone Life Sciences $400m duvakitug financing
Lucid Diligence Brief: Teva and Blackstone Life Sciences $400m duvakitug…
Immunology Today—March 4, 2026
This week's Immunology update covers key regulatory actions, clinical trial…
Immunology Video Recap—February 25, 2026
This biweekly Immunology video recap highlights key developments across…